MATN
Mateon Therapeutics, Inc.
MATN
MATN
Delisted
MATN was delisted on the 7th of December, 2016.
21 hedge funds and large institutions have $1.42M invested in Mateon Therapeutics, Inc. in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $13K
Holders
21
Holding in Top 10
–
Calls
–
Puts
$13K
Top Buyers
| 1 | +$30.4K | |
| 2 | +$21.8K | |
| 3 | +$8.89K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$2.99K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.55K |
Top Sellers
| 1 | -$14K | |
| 2 | -$10K | |
| 3 | -$7K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6.71K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$2.17K |